Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: the PANCOVID Randomized Clinical Trial
Clinical infectious diseases/Clinical infectious diseases (Online University of Chicago Press)(2022)
Key words
COVID-19,tenofovir disoproxil fumarate,emtricitabine,baricitinib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined